Pharmaceutical Discount Agreements From April 1, 2025 For Various Active Ingredients Within The Framework Of An Open-House Procedure

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 102619294

  Document Type - Tender Notices

Description - Description: The subject of this publication is the conclusion of contracts pursuant to Section 130a Paragraph 8 SGB V for several active ingredients within the framework of a so-called open house procedure: Subject to uniform contractual conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or groups of pharmaceutical companies are offered the conclusion of discount contracts pursuant to Section 130a Paragraph 8 SGB V for the following active ingredients: Clobetasol (D07AD01) Sodium oxybate (N01AX11, N07XX04) Tafluprost (S01EE05) Telmisartan & Amlodipine (C09DB04) Therapeutic allergen tree pollen (V01AA05) Therapeutic allergen grass pollen (V01AA02)

Gt Ref Id - 102619294

Deadline - Feb 01, 2027